![Jean-Loup Romet-Lemonne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Loup Romet-Lemonne
Direktor/Vorstandsmitglied bei Antabio SAS
Profil
Jean-Loup Romet-Lemonne is currently the Director at Antabio SAS.
Previously, he held the position of Director at Natural Implant SA. From 1993 to 2007, he was the Director at IDM Pharma, Inc. He also worked as a Professor at Harvard University.
Aktive Positionen von Jean-Loup Romet-Lemonne
Unternehmen | Position | Beginn |
---|---|---|
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jean-Loup Romet-Lemonne
Unternehmen | Position | Ende |
---|---|---|
IDM Pharma, Inc.
![]() IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 16.07.2007 |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Natural Implant SA
![]() Natural Implant SA Medical SpecialtiesHealth Technology Natural Implant SA develops and manufactures dental implants from biomaterial. The company manufactures a novel type of dental implant made from an FDA biomaterial around which it grows periodontal ligament cells using tissue engineering techniques. Natural Implant was founded in 1998 and is headquartered in Brest, France. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Natural Implant SA
![]() Natural Implant SA Medical SpecialtiesHealth Technology Natural Implant SA develops and manufactures dental implants from biomaterial. The company manufactures a novel type of dental implant made from an FDA biomaterial around which it grows periodontal ligament cells using tissue engineering techniques. Natural Implant was founded in 1998 and is headquartered in Brest, France. | Health Technology |
IDM Pharma, Inc.
![]() IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Health Technology |